Insider Sale: SVP of $CLMT Sells 25,123 Shares

Gregory J. Morical, SVP of $CLMT, sold 25,123 shares on June 16, 2025, for approximately $419,302, representing nearly 39% of their holdings in that class of stock. Over the past six months, $CLMT insiders have predominantly sold shares, with 13 sales and only one purchase, while IFP ADVISORS, INC decreased their holdings by 100% in Q4 2024. UBS issued a sell rating on $CLMT in February 2025, adding to the negative sentiment.

Analysis

Recent insider trading activity at Calumet, Inc. ($CLMT) reveals a strong bearish sentiment from within the company. SVP Gregory J. Morical's sale of 25,123 shares on June 16, 2025, for approximately $419,302, reduced his holdings of that class of stock by a significant 38.9%, leaving him with 39,415 shares. This transaction is part of a broader pattern observed over the past six months, during which $CLMT insiders executed 13 sales against only one purchase. Notably, Jennifer Straumins sold 287,861 shares for an estimated $4.5 million, and Daniel L. Sheets sold 40,000 shares for $554,200. The sole insider purchase was made by EVP CFO David Lunin, acquiring 2,500 shares for $32,625. This overwhelming selling pressure from insiders is compounded by negative institutional sentiment; IFP ADVISORS, INC. liquidated its entire 2,000-share position in Q4 2024. Furthermore, Wall Street analyst coverage reflects this negativity, with UBS issuing a "Sell" rating on February 4, 2025, and no firms reporting buy ratings in recent months. The confluence of substantial insider sales, waning institutional interest, and a direct sell rating paints a challenging picture for $CLMT, corroborated by an extremely negative sentiment score of -0.85.

Key Decisions for Investors

• Investors should view the significant and widespread insider selling at $CLMT, including a nearly 39% reduction in holdings by an SVP, as a strong cautionary signal regarding the company's internal outlook.
• The lack of new institutional investment, coupled with existing holders like IFP ADVISORS exiting their positions and a 'Sell' rating from UBS, suggests a need for thorough due diligence before initiating or increasing exposure to $CLMT.
• Consider monitoring for any reversal in insider selling trends or positive analyst rating changes before considering a bullish stance, as current indicators point towards continued headwinds for the stock.